Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
出版年份 2019 全文链接
标题
Quantifying atherogenic lipoproteins for lipid-lowering strategies: consensus-based recommendations from EAS and EFLM
作者
关键词
-
出版物
CLINICAL CHEMISTRY AND LABORATORY MEDICINE
Volume 58, Issue 4, Pages 496-517
出版商
Walter de Gruyter GmbH
发表日期
2019-12-19
DOI
10.1515/cclm-2019-1253
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Lipoprotein(a), PCSK9 Inhibition and Cardiovascular Risk: Insights from the FOURIER Trial
- (2019) Michelle L. O'Donoghue et al. CIRCULATION
- Apolipoprotein profiling as a personalized approach to the diagnosis and treatment of dyslipidaemia
- (2019) L Renee Ruhaak et al. ANNALS OF CLINICAL BIOCHEMISTRY
- Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease
- (2019) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Biological variation data for lipid cardiovascular risk assessment biomarkers. A systematic review applying the biological variation data critical appraisal checklist (BIVAC)
- (2019) Jorge Díaz–Garzón Marco et al. CLINICA CHIMICA ACTA
- Lipoprotein(a) reductions from PCSK9 inhibition and major adverse cardiovascular events: Pooled analysis of alirocumab phase 3 trials
- (2019) Kausik K. Ray et al. ATHEROSCLEROSIS
- Comparison of Conventional Lipoprotein Tests and Apolipoproteins in the Prediction of Cardiovascular Disease: Data from UK Biobank
- (2019) Claire Welsh et al. CIRCULATION
- Performance of LDL-C calculated with Martin's formula compared to the Friedewald equation in familial combined hyperlipidemia
- (2018) Roopa Mehta et al. ATHEROSCLEROSIS
- Impact of Novel Low-Density Lipoprotein-Cholesterol Assessment on the Utility of Secondary Non-High-Density Lipoprotein-C and Apolipoprotein B Targets in Selected Worldwide Dyslipidemia Guidelines
- (2018) Vasanth Sathiyakumar et al. CIRCULATION
- Update on the laboratory investigation of dyslipidemias
- (2018) I. Ramasamy CLINICA CHIMICA ACTA
- Joint EFLM-COLABIOCLI Recommendation for venous blood sampling
- (2018) Ana-Maria Simundic et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Apolipoprotein B measurement: Need for standardization
- (2018) John H. Contois et al. Journal of Clinical Lipidology
- A comparison of three apolipoprotein B methods and their associations with incident coronary heart disease risk over a 12-year follow-up period: The Multi-Ethnic Study of Atherosclerosis
- (2018) Jing Cao et al. Journal of Clinical Lipidology
- Pediatric lipid reference values in the general population: The Dutch lifelines cohort study
- (2018) J.W. Balder et al. Journal of Clinical Lipidology
- Relationship of Lipoprotein(a) Molar Concentrations and Mass According to Lipoprotein(a) Thresholds and Apolipoprotein(a) Isoform Size
- (2018) Sotirios Tsimikas et al. Journal of Clinical Lipidology
- NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis
- (2018) Sotirios Tsimikas et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparability of Lipoprotein Particle Number Concentrations Across ES-DMA, NMR, LC-MS/MS, Immunonephelometry, and VAP: In Search of a Candidate Reference Measurement Procedure for apoB and non-HDL-P Standardization
- (2018) Vincent Delatour et al. CLINICAL CHEMISTRY
- Which Lipids Should Be Analyzed for Diagnostic Workup and Follow-up of Patients with Hyperlipidemias?
- (2018) Michel R. Langlois et al. Current Cardiology Reports
- High lipoprotein(a) and high risk of mortality
- (2018) Anne Langsted et al. EUROPEAN HEART JOURNAL
- 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
- (2018) Scott M. Grundy et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials
- (2018) Peter Willeit et al. LANCET
- Comparing a novel equation for calculating low-density lipoprotein cholesterol with the Friedewald equation: A VOYAGER analysis
- (2018) Michael K. Palmer et al. CLINICAL BIOCHEMISTRY
- Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
- (2017) Brian A. Ference et al. EUROPEAN HEART JOURNAL
- Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
- (2017) Brian A. Ference et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Test in Context: Lipoprotein(a)
- (2017) Sotirios Tsimikas JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- A Test in Context: Lipid Profile, Fasting Versus Nonfasting
- (2017) Børge G. Nordestgaard JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy
- (2017) Vasanth Sathiyakumar et al. CIRCULATION
- 2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult
- (2016) Todd J. Anderson et al. CANADIAN JOURNAL OF CARDIOLOGY
- Efficacy and Safety of the PCSK9 Inhibitor Evolocumab in Patients with Mixed Hyperlipidemia
- (2016) Robert S. Rosenson et al. CARDIOVASCULAR DRUGS AND THERAPY
- Reductions in Atherogenic Lipids and Major Cardiovascular EventsClinical Perspective
- (2016) Kausik K. Ray et al. CIRCULATION
- Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease
- (2016) Børge G. Nordestgaard CIRCULATION RESEARCH
- Pediatric reference data of serum lipids and prevalence of dyslipidemia: Results from a population-based cohort in Germany
- (2016) Anne Dathan-Stumpf et al. CLINICAL BIOCHEMISTRY
- Association Between Lowering LDL-C and Cardiovascular Risk Reduction Among Different Therapeutic Interventions
- (2016) Michael G. Silverman et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology
- (2016) Børge G. Nordestgaard et al. JOURNAL OF LIPID RESEARCH
- Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials
- (2016) Nicholas J Viney et al. LANCET
- Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State
- (2015) K. T. White et al. CLINICAL CHEMISTRY
- Automated Multiplex LC-MS/MS Assay for Quantifying Serum Apolipoproteins A-I, B, C-I, C-II, C-III, and E with Qualitative Apolipoprotein E Phenotyping
- (2015) I. van den Broek et al. CLINICAL CHEMISTRY
- ‘LDL-C’ = LDL-C + Lp(a)-C
- (2015) Calvin Yeang et al. CURRENT OPINION IN LIPIDOLOGY
- Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment
- (2015) Albert Wiegman et al. EUROPEAN HEART JOURNAL
- Residual dyslipidemia according to low-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010
- (2015) Nathan D. Wong et al. Journal of Clinical Lipidology
- Lipoprotein(a): Fasting and nonfasting levels, inflammation, and cardiovascular risk
- (2014) Anne Langsted et al. ATHEROSCLEROSIS
- Clinical impact of direct HDLc and LDLc method bias in hypertriglyceridemia. A simulation study of the EAS-EFLM Collaborative Project Group
- (2014) Michel R. Langlois et al. ATHEROSCLEROSIS
- Low Nonfasting Triglycerides and Reduced All-Cause Mortality: A Mendelian Randomization Study
- (2014) M. Thomsen et al. CLINICAL CHEMISTRY
- Triglycerides and cardiovascular disease
- (2014) Børge G Nordestgaard et al. LANCET
- Discordance of Low-Density Lipoprotein (LDL) Cholesterol With Alternative LDL-Related Measures and Future Coronary Events
- (2013) Samia Mora et al. CIRCULATION
- From biomarkers to medical tests: The changing landscape of test evaluation
- (2013) Andrea R. Horvath et al. CLINICA CHIMICA ACTA
- Standardization of collection requirements for fasting samples
- (2013) A.M. Simundic et al. CLINICA CHIMICA ACTA
- Association of Apolipoprotein B and Nuclear Magnetic Resonance Spectroscopy-Derived LDL Particle Number with Outcomes in 25 Clinical Studies: Assessment by the AACC Lipoprotein and Vascular Diseases Division Working Group on Best Practices
- (2013) T. G. Cole et al. CLINICAL CHEMISTRY
- Comparison of a Novel Method vs the Friedewald Equation for Estimating Low-Density Lipoprotein Cholesterol Levels From the Standard Lipid Profile
- (2013) Seth S. Martin et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Lipoprotein(a): resurrected by genetics
- (2013) F. Kronenberg et al. JOURNAL OF INTERNAL MEDICINE
- Friedewald-Estimated Versus Directly Measured Low-Density Lipoprotein Cholesterol and Treatment Implications
- (2013) Seth S. Martin et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Non–High-Density Lipoprotein Cholesterol, Guideline Targets, and Population Percentiles for Secondary Prevention in 1.3 Million Adults
- (2013) Mohamed B. Elshazly et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The polygenic nature of hypertriglyceridaemia: implications for definition, diagnosis, and management
- (2013) Robert A Hegele et al. Lancet Diabetes & Endocrinology
- Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials
- (2012) Jennifer G. Robinson et al. AMERICAN JOURNAL OF CARDIOLOGY
- Substituting non-HDL cholesterol with LDL as a guide for lipid-lowering therapy increases the number of patients with indication for therapy
- (2012) Luís Masana et al. ATHEROSCLEROSIS
- Closing the Gaps in Pediatric Laboratory Reference Intervals: A CALIPER Database of 40 Biochemical Markers in a Healthy and Multiethnic Population of Children
- (2012) D. A. Colantonio et al. CLINICAL CHEMISTRY
- Association of LDL Cholesterol, Non–HDL Cholesterol, and Apolipoprotein B Levels With Risk of Cardiovascular Events Among Patients Treated With Statins
- (2012) S. Matthijs Boekholdt et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Comparisons of Apolipoprotein B Levels Estimated by Immunoassay, Nuclear Magnetic Resonance, Vertical Auto Profile, and Non-High-Density Lipoprotein Cholesterol in Subjects With Hypertriglyceridemia (SAFARI Trial)
- (2011) Scott M. Grundy et al. AMERICAN JOURNAL OF CARDIOLOGY
- Triglycerides and Cardiovascular Disease
- (2011) Michael Miller et al. CIRCULATION
- A Meta-Analysis of Low-Density Lipoprotein Cholesterol, Non-High-Density Lipoprotein Cholesterol, and Apolipoprotein B as Markers of Cardiovascular Risk
- (2011) Allan D. Sniderman et al.
- Non-HDL Cholesterol Shows Improved Accuracy for Cardiovascular Risk Score Classification Compared to Direct or Calculated LDL Cholesterol in a Dyslipidemic Population
- (2011) H. E. van Deventer et al. CLINICAL CHEMISTRY
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- Reliability of low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B measurement
- (2011) John H. Contois et al. Journal of Clinical Lipidology
- Seven Direct Methods for Measuring HDL and LDL Cholesterol Compared with Ultracentrifugation Reference Measurement Procedures
- (2010) W. G. Miller et al. CLINICAL CHEMISTRY
- Lipoprotein(a) as a cardiovascular risk factor: current status
- (2010) Børge G. Nordestgaard et al. EUROPEAN HEART JOURNAL
- Advanced Lipoprotein Testing and Subfractionation Are Not (Yet) Ready for Routine Clinical Use
- (2009) Samia Mora CIRCULATION
- Comparison of LDL Cholesterol Concentrations by Friedewald Calculation and Direct Measurement in Relation to Cardiovascular Events in 27 331 Women
- (2009) S. Mora et al. CLINICAL CHEMISTRY
- Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
- (2009) J. H. Contois et al. CLINICAL CHEMISTRY
- Major Lipids, Apolipoproteins, and Risk of Vascular Disease
- (2009) The Emerging Risk Factors Collaboration* JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Meta-Analysis of the Relationship Between Non–High-Density Lipoprotein Cholesterol Reduction and Coronary Heart Disease Risk
- (2009) Jennifer G. Robinson et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Fasting Compared With Nonfasting Lipids and Apolipoproteins for Predicting Incident Cardiovascular Events
- (2008) Samia Mora et al. CIRCULATION
- Reference intervals: the way forward
- (2008) F. Ceriotti et al. ANNALS OF CLINICAL BIOCHEMISTRY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation